Home/Academy/Journal Finder/The Lancet Infectious Diseases
The Lancet Infectious Diseases
The Lancet Group (Elsevier)
Clinical and public health research, reviews and commentary on infectious diseases, including trials, antimicrobial resistance, vaccines and global health.
Overview
The Lancet Infectious Diseases is published by The Lancet Group (Elsevier). Clinical and public health research, reviews and commentary on infectious diseases, including trials, antimicrobial resistance, vaccines and global health.
Key information
Editor, scope, metrics, indexing, fees and policies are from the journal's Lancet Group pages (aims and scope, Information for Authors of August 2026, submission guidelines, content types, open access, formatting guidelines and article templates), read November 2026. Submission volume is not published.
Aims & scope
The Lancet Infectious Diseases publishes original research that advocates change in or illuminates infectious disease clinical practice, and informative reviews on any topic connected with infectious diseases and human health. Topics include, but are not limited to:
- Anti-infective therapy and immunisation
- Bacterial, viral, fungal and parasitic infections
- Emerging infectious diseases
- HIV/AIDS, malaria, and tuberculosis and mycobacterial infections
- Infection control
- Infectious diseases epidemiology
- Neglected tropical diseases
- Travel medicine
The journal prefers articles likely to influence clinical practice or thinking. It also publishes Series and Commissions intended to shape clinical practice and health policy in areas of need in infectious diseases.
Reporting guidelines accepted
Article
- Text
- Up to 3,500 words (4,500 for randomised trials)
- Abstract
- Summary up to 250 words
- References
- Up to 30
- Tables / figures
- 3–6 tables and figures as a guide
Review
- Text
- Up to 4,500 words
- Abstract
- 150-word unstructured summary
- References
- Up to 150
- Tables / figures
- About five illustrations
Historical Review
- Text
- As for Reviews
- Abstract
- As for Reviews
- References
- As for Reviews
- Tables / figures
- As for Reviews
Personal View
- Text
- Up to 4,500 words
- Abstract
- Not stated
- References
- Up to 75
- Tables / figures
- Not stated
Grand Round
- Text
- Case report 800 words; review 3,000 words
- Abstract
- Not stated
- References
- Up to 75
- Tables / figures
- Not stated
Clinical Picture
- Text
- Up to 300 words
- Abstract
- Not stated
- References
- None
- Tables / figures
- Not stated
Comment
- Text
- Up to 750 words
- Abstract
- Not stated
- References
- Up to 10
- Tables / figures
- Not stated
Correspondence
- Text
- Up to 400 words
- Abstract
- Not stated
- References
- No more than 5
- Tables / figures
- One table or figure only
Newsdesk
- Text
- Not stated
- Abstract
- Not stated
- References
- Not stated
- Tables / figures
- Not stated
Media Watch
- Text
- 800–850 words
- Abstract
- Not stated
- References
- Not stated
- Tables / figures
- Not stated
Editorial
- Text
- Not stated
- Abstract
- Not stated
- References
- Not stated
- Tables / figures
- Not stated
Commissions
- Text
- Not stated
- Abstract
- Not stated
- References
- Not stated
- Tables / figures
- Not stated
Series
- Text
- Not stated
- Abstract
- Not stated
- References
- Not stated
- Tables / figures
- Not stated
Important notes
- Word limits exclude the abstract, references, table titles, figure legends and footnotes unless stated otherwise.
- Requirements vary by article type and are set by the publisher — confirm against the live author guidelines before submitting.
- The Summary limit is 250 words in the Information for Authors (August 2026) but 300 words in the July 2025 formatting guidelines and templates; confirm with the editorial office. Word counts are for the main text only. Comment, Correspondence, Newsdesk, Media Watch and Editorial are not usually externally peer reviewed.
General formatting rules that apply across article types. Specific word, abstract, reference and figure limits vary by article type — see the Article types tab for those.
General requirements
Manuscript template
Optional Word templates for general Articles, observational studies, randomised trials, and systematic reviews and meta-analyses. Submit text and tables in Word with reference-manager fields removed, figures as editable files, and supplementary material as one PDF with a contents list and numbered pages. Single spaces after sentences, midline decimals (23·4), no bold for emphasis, no automatic hyphenation, endnotes, headers or footers; add line numbers
Information on the submission process and the ethics and publication standards The Lancet Infectious Diseases applies.
Submission process
Ethics & publication standards
Lancet journals are ICMJE signatories and follow the COPE code of conduct. Review is single-anonymised: in-house editors read every submission, then research papers go to at least two reviewers and a statistician. Work must be original and not under consideration elsewhere; Reviews and similar non-research material are checked with CrossCheck. Appeals go to infectiousdiseases@lancet.com, and unresolved complaints to the Ombudsperson.
Author declarations
- AuthorshipAll four ICMJE criteria; every author's contribution is stated at the end of the text, and all authors sign the author statement form (after peer review for Articles; at submission for Reviews, Personal Views, Comments and Correspondence)
- Data verificationMore than one author must have directly accessed and verified the underlying data (an academic author if there is a commercial partnership), and all authors confirm full access to the data
- Declaration of interestsEvery author discloses financial and personal relationships within 3 years, even if unrelated to the work; the statement must match the ICMJE form
- Role of the funding sourceA subheading at the end of Methods describes the sponsor's role; all funding is declared in the acknowledgments
- Ethics and consentName the approving committee and approval number (both published); written consent for case details or images (signed forms are not sent to the journal); an Equitable Partnership Declaration is requested at revision for papers set in low- or middle-income countries
- Trial registrationEvery interventional trial is registered before the first participant in a WHO ICTRP primary register or ClinicalTrials.gov; trial reports follow CONSORT 2025 and are submitted with the full protocol
- Data sharingEvery research Article carries a data sharing statement covering what is shared, when, where and on what access terms ('undecided' is not accepted); raw data may be requested for up to 10 years
- Generative AIDisclose its use in a statement at the end of the manuscript (grammar checks exempt); AI cannot be an author; in Comments and Correspondence it may only assist with grammar and spelling
From the journal's Information for Authors (August 2026). Check the live author guidelines for the full list of documents required at submission.
Reporting guidelines to use
Use the guideline matching your study design — these are the reporting checklists the journal accepts, not a list of required documents we've independently verified.
Named in the Information for Authors (August 2026). CONSORT extensions (cluster trials, harms, CONSORT-C for ages 0–19, CONSORT-AI) and SPIRIT-AI apply where relevant. Send the checklist and trial protocol with the submission.
Author guidelines
Read the complete and latest author instructions on the journal website.
View author guidelinesData availability
All research Articles must end with a data sharing statement saying whether individual participant data and a data dictionary will be shared, what, when, where (with URLs) and by what access criteria; trials enrolling from 1 January 2019 must also include a data sharing plan in the trial registration. Mendeley Data DOIs can be cited, and novel gene sequences go to a public database.
Declaration headings are taken from The Lancet Infectious Diseases's own submission guidelines — check the live author guidelines before submitting, as they can change.
Sample articles
Recent, relevant articles published in The Lancet Infectious Diseases. These examples help you understand the journal's scope, style and expected quality — we only list one once its title, DOI, year and article type are verified against the publisher's own page.
Filter examples
Article type
Learn from examples
- Review the structure, formatting and presentation style the journal actually publishes.
- Use examples together with the Article types and Manuscript specs tabs, not as a substitute for the journal's own guidelines.
- Check article-type-specific requirements before drafting.
Seven of the eight were confirmed against their PubMed records (title, authors, date, volume, issue, pages and DOI). The Newsdesk item (November 2026) is too recent to appear in PubMed and is listed from its DOI and the journal's table of contents. Types are the journal's own section labels.
General stages a manuscript moves through at most peer-reviewed journals — this sequence is standard academic-publishing practice, not a claim we've verified against The Lancet Infectious Diseases's own workflow. Durations below are shown only where the publisher has actually disclosed them.
Manuscript submitted via the journal's submission system.
Administrative and scope check by the editorial office.
Editor decides whether to send the manuscript for peer review.
External review by expert referees.
Accept, minor/major revision, or reject.
Author submits a revised manuscript, if requested.
Editor confirms acceptance.
Online-first, then the print/issue assignment if applicable.
Key timeline statistics
Timeline by article type
No median first-decision time is published. Only fast-track Articles (eligible original research of immediate public health or clinical importance, requested at submission) have a stated turnaround: peer review in 3–5 days and publication within 10 weeks. No other article type has a published turnaround.
Factors that may affect timeline
- Type and complexity of the study
- Speed of author response to reviewer comments
- Number of revision rounds
- Availability of expert reviewers
- Editorial and production workload
- Compliance with the journal's own guidelines
General tips for faster processing
- Confirm the manuscript fits the journal's scope before submitting
- Follow the author guidelines and formatting requirements closely
- Respond to reviewer comments completely and promptly
- Submit all required documents and declarations at the time of submission
The stage sequence and general tips above reflect typical academic-publishing practice, not data we've verified against The Lancet Infectious Diseases specifically. Any duration we haven't independently confirmed from the publisher reads as "not yet verified" rather than an estimate.
Indexing and abstracting services
MEDLINE/PubMed, Scopus, Web of Science (Science Citation Index Expanded) and Embase as listed by the journal; it also lists CAB Direct, Chemical Abstracts, CINAHL, Current Contents/Clinical Medicine, Essential Science Indicators and Crossref. Not in DOAJ, which lists only fully open-access journals. EBSCOhost, ProQuest and OCLC WorldCat are not listed by the journal.
Citation metrics
Impact Factor is Clarivate's JCR figure, CiteScore and SNIP are Scopus metrics and SJR is SCImago's. Only the 2025 Impact Factor and CiteScore appear on the journal's own pages; earlier years, SJR and SNIP were not on the pages reviewed. Years with no bar have no figure on record here. Read November 2026; confirm on JCR, Scopus or SCImago before citing.
Impact Factor is Clarivate's JCR figure, CiteScore and SNIP are Scopus metrics and SJR is SCImago's. Only the 2025 Impact Factor and CiteScore appear on the journal's own pages; earlier years, SJR and SNIP were not on the pages reviewed. Years with no bar have no figure on record here. Read November 2026; confirm on JCR, Scopus or SCImago before citing.
Impact Factor is Clarivate's JCR figure, CiteScore and SNIP are Scopus metrics and SJR is SCImago's. Only the 2025 Impact Factor and CiteScore appear on the journal's own pages; earlier years, SJR and SNIP were not on the pages reviewed. Years with no bar have no figure on record here. Read November 2026; confirm on JCR, Scopus or SCImago before citing.
Impact Factor is Clarivate's JCR figure, CiteScore and SNIP are Scopus metrics and SJR is SCImago's. Only the 2025 Impact Factor and CiteScore appear on the journal's own pages; earlier years, SJR and SNIP were not on the pages reviewed. Years with no bar have no figure on record here. Read November 2026; confirm on JCR, Scopus or SCImago before citing.
Journal quartile
Scopus and Web of Science classify journals into their own category sets — we show the one subject category we've confirmed rather than listing categories we haven't checked.
Additional metrics
CiteScore details (2025)
Metric notes
- The journal's about page lists an Impact Factor of 29.4, a CiteScore of 39.2 and a 5-year Impact Factor of 26, without stating the year of each. It ranks the journal first of 141 infectious diseases journals (2025 Journal Citation Reports) and third of 361 (Scopus); Q1 follows from that rank.
- CiteScore 2025: 31,456 citations in 2022–2025 to 803 documents published in those years (31,456 / 803 = 39.2).
- The h-index (317), SJR and SNIP values were not on the journal's own pages; confirm them on SCImago or Scopus before citing.
Hybrid journal: open access is offered only for research Articles whose funder or institution has an agreement with the publisher; the charge is paid on acceptance.
Publication charges (APC)
Additional charges
Check current fees
Publication-charge and open-access policy pages change independently of this profile.
Fees and fundingLicence & copyright
- Licence: Gold open access: CC BY or CC BY-NC-ND (the open access section also names CC BY-NC; confirm, and check the funder's preferred licence)
- Copyright: Subscription route: authors sign an exclusive publishing agreement (transfer of copyright) with Elsevier. Gold open-access authors retain copyright
Based on what The Lancet Group (Elsevier) has publicly stated for The Lancet Infectious Diseases as of our last check (2026) — verify current fees and policy on the journal website before budgeting or submitting.
- Best fit for original research likely to change clinical practice or thinking about a disease, written clearly for readers outside the specialty.
- In-house editors read every submission and many are declined at that stage; research papers then go to at least two reviewers and a statistician, and need a Research in context panel and a data sharing statement.
- Request fast-track in the covering letter for work of immediate public health or clinical importance: peer review in 3–5 days and publication within 10 weeks if accepted.
- After rejection, papers may be transferred to other Lancet or Elsevier journals. Articles set in low- or middle-income countries need an Equitable Partnership Declaration at revision.
These notes are Pubrica's own read of the journal's published guidelines, not a claim about editorial preference or acceptance likelihood.
Verified against the journal's Lancet Group pages (Information for Authors, August 2026; open access and formatting guidelines), read November 2026, and PubMed records for the sample articles.